Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer

Lung Cancer

Volumn 44, Issue 3, 2004, Pages 317-325

  Cheran, Sendhil Kumar ^a   Herndon II, James E ^b   Patz Jr , Edward F ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bone scintigraphy; Lung cancer; Osseous metastasis; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; STATISTICAL MODEL; WHOLE BODY RADIATION;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 2342519344     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.11.008     Document Type: Article

References (16)

1. Beadsmore C.J., Screaton N.J. Classification, staging, and prognosis of lung cancer. Eur. J. Radiol. 45:2003;8-17
2. Pope R.J.E., Hansell D.M. Extra-thoracic staging of lung cancer. Eur. J. Radiol. 45:2002;31-38
3. van Tinteren H., Hoekstra O.S., Smit E.F., et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 359:2002;1388-1392
4. Pieterman R.M., van Putten J.W.G., Meuzelaar J.J., et al. Preoperative staging of non-small cell lung cancer with positron-emission tomography. N. Engl. J. Med. 343:2000;254-261
5. Gould M., Maclean C., Kuschner W., Rydzak C., Owens D. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 285:2001;914-924
6. Marom E.M., McAdams H.P., Erasmus J.J., et al. Staging non-small cell lung cancer with whole-body PET. Radiology. 212:1999;803-809
7. Bury T., Barreto A., Daenen F., Barthelemy N., Ghaye B., Rigo P. Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer. Eur. J. Nucl. Med. 25:1998;1244-1247
8. 18F -2-deoxyglucose positron emission tomography and technetium-99 m methylene diphosphate bone scan to detect bone metastases in patients with non-small cell lung cancer Neoplasma. 49:2002;267-271
9. 18F -fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer Mol. Imag. Biol. 5:2003;26-31
10. Reid M.C., Lachs M.S., Feinstein A.R. Use of methodological standards in diagnostic test research: getting better but still not good. JAMA. 274:1995;645-651
11. Simel D.L., Feussner J.R., Delong E.R., Matchar D.B. Intermediate, indeterminate, and uninterpretable diagnostic test results. Med. Decis. Making. 7:1987;107-114
12. Ludbrook J. Statistical techniques for comparing measurers and methods of measurement: a critical review. Clin. Exp. Pharmacol. Physiol. 29:2002;527-536
13. Dominioni L., Imperatori A., Rovera F., Ochetti A., Torrigiotti G., Paolucci M. Stage I nonsmall cell lung carcinoma. Cancer. 89:2000;2334-2344
14. Toloza E.M., Harpole L., McCrory D.C. Noninvasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 123(Suppl):2003;137S- 146S
15. 18F -fluorodeoxyglucose positron emission tomography AJR Am. J. Roentgenol. 168:1997;1357-1360
16. Smith R.A., Glynn T.J. Early lung cancer detection, current and ongoing challenges. Cancer. 89:2000;2327-2328